Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors

被引:422
作者
Abramsson, A [1 ]
Lindblom, P [1 ]
Betsholtz, C [1 ]
机构
[1] Univ Gothenburg, Dept Biochem Med, Sahlagrenska Acad, SE-40530 Gothenburg, Sweden
关键词
D O I
10.1172/JCI200318549
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tumor-infiltrating blood vessels deviate morphologically and biochemically from normal vessels, raising the prospect of selective pharmacological targeting. Current antiangiogenic approaches focus mainly on endothelial cells, but recent data imply that targeting pericytes may provide additional benefits. Further development of these concepts will require deeper insight into mechanisms of pericyte recruitment and function in tumors. Here, we applied genetic tools to decipher the function of PDGF-B and PDGF-Rbeta in pericyte recruitment in a mouse fibrosarcoma model. In tumors transplanted into PDGF-B retention motif-deficient (pdgf-b(ret/ret)) mice, pericytes were fewer and were partially detached from the vessel wall, coinciding with increased tumor vessel diameter and hemorrhaging. Transgenic PDGF-B expression in tumor cells was able to increase the pericyte density in both WT and pdgf-b(ret/ret) mice but failed to correct the pericyte detachment in pdgf-b(ret/ret) mice. Coinjection of exogenous pericytes and tumor cells showed that pericytes require PDGF-Rbeta for recruitment to tumor vessels, whereas endothelial PDGF-B retention is indispensable for proper integration of pericytes in the vessel wall. Our data support the notion that pericytes serve an important function in tumor vessels and highlight PDGF-B and PDGF-Rbeta as promising molecular targets for therapeutic intervention.
引用
收藏
页码:1142 / 1151
页数:10
相关论文
共 48 条
[1]   Analysis of mural cell recruitment to tumor vessels [J].
Abramsson, A ;
Berlin, Ö ;
Papayan, H ;
Paulin, D ;
Shani, M ;
Betsholtz, C .
CIRCULATION, 2002, 105 (01) :112-117
[2]   Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].
Arap, W ;
Pasqualini, R ;
Ruoslahti, E .
SCIENCE, 1998, 279 (5349) :377-380
[3]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[4]  
BERGMANN BM, 1987, SLEEP, V10, P1
[5]   ANALOGOUS ALTERNATIVE SPLICING [J].
BETSHOLTZ, C ;
RORSMAN, F ;
WESTERMARK, B ;
OSTMAN, A ;
HELDIN, CH .
NATURE, 1990, 344 (6264) :299-299
[6]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[7]  
Eberhard A, 2000, CANCER RES, V60, P1388
[8]   Regulation of the spatial organization of mesenchymal connective tissue -: Effects of cell-associated versus released isoforms of platelet-derived growth factor [J].
Eming, SA ;
Yarmush, ML ;
Krueger, GG ;
Morgan, JR .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (01) :281-289
[9]   Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy [J].
Enge, M ;
Bjarnegård, M ;
Gerhardt, H ;
Gustafsson, E ;
Kalén, M ;
Asker, N ;
Hammes, HP ;
Shani, M ;
Fässler, R ;
Betsholtz, C .
EMBO JOURNAL, 2002, 21 (16) :4307-4316
[10]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182